Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
76.30
0.00 (0.00%)
Sep 3, 2026, 9:59 AM IDT

Novolog (Pharm-Up 1966) Financials Overview

Millions ILS. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,8151,8052,0221,6431,5081,255
Revenue Growth
-10.98%-10.70%23.01%8.99%20.13%10.73%
Gross Profit
156.13155.83184.95173.76179.7154.67
Operating Income
45.5945.7872.753.9777.8169.41
Net Income
-0.674.1239.54-4247.5142.32
Earnings Per Share
-0.000.010.08-0.080.090.08
EPS Growth
--89.54%--12.20%-3.53%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
The Digital Division
27.3526.3126.2925.9825.82
Logistics Division
1,5631,7901,4001,2821,098
Unallocated Adjustments
-2.63-1.51-1.82-1.62-9.25
Health Services Division
217.88206.73218.59201.85140.84
Total
1,8052,0221,6431,5081,255

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
204.46121.77247.6232.94172.81238.71
Total Debt
171.19183.2198.47215.18212.77166.81
Net Cash (Debt)
33.27-61.4449.1317.76-39.9771.9
Net Cash Growth
18.55%-176.64%--223.81%
Net Cash Per Share
0.07-0.120.100.03-0.080.14

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
89.03-0.73158.52200.01132.6583.39
Capital Expenditures
-23.11-17.72-13.39-36.25-44.97-30.64
Free Cash Flow
65.92-18.45145.12163.7787.6852.75
Free Cash Flow Growth
-25.31%--11.38%86.79%66.21%60.48%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
8.60%8.63%9.15%10.57%11.92%12.32%
Operating Margin
2.51%2.54%3.60%3.28%5.16%5.53%
Pretax Margin
0.08%0.38%2.85%-1.76%4.50%4.79%
Profit Margin
-0.04%0.23%1.96%-2.56%3.15%3.37%
FCF Margin
3.63%-1.02%7.18%9.96%5.81%4.20%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0390.0390.0490.0290.0660.094
Dividend Per Share Growth
-50.03%-20.02%66.66%-55.24%-30.00%262.10%
Dividend Yield
5.20%3.12%2.78%2.23%2.60%3.54%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-155.9323.39-29.6635.53
Forward PE
-14.0214.0214.0214.0214.02
P/FCF Ratio
5.91-6.374.4316.0728.51
PS Ratio
0.210.360.460.440.931.20